Showing 1 - 5 results of 5 for search 'Julie Irving', query time: 0.02s Refine Results
  1. 1
    Flow minimal residual disease monitoring of candidate leukemic stem cells defined by the immunophenotype, CD34+CD38lowCD19+ in B-lineage childhood acute lymphoblastic leukemia

    Flow minimal residual disease monitoring of candidate leukemic stem cells defined by the immunophenotype, CD34+CD38lowCD19+ in B-lineage childhood acute lymphoblastic leukemia by Kerrie Wilson, Marian Case, Lynne Minto, Simon Bailey, Nick Bown, Jenny Jesson, Sarah Lawson, Josef Vormoor, Julie Irving

    Published 2010-04-01
    Get full text
    Article
  2. 2
    Acute B lymphoblastic leukaemia‐propagating cells are present at high frequency in diverse lymphoblast populations

    Acute B lymphoblastic leukaemia‐propagating cells are present at high frequency in diverse lymphoblast populations by Klaus Rehe, Kerrie Wilson, Simon Bomken, Daniel Williamson, Julie Irving, Monique L. den Boer, Martin Stanulla, Martin Schrappe, Andrew G. Hall, Olaf Heidenreich, Josef Vormoor

    Published 2012-12-01
    Get full text
    Article
  3. 3
    Selumetinib in combination with dexamethasone for the treatment of relapsed/refractory RAS-pathway mutated paediatric and adult acute lymphoblastic leukaemia (SeluDex): study protocol for an international, parallel-group, dose-finding with expansion phase I/II trial

    Selumetinib in combination with dexamethasone for the treatment of relapsed/refractory RAS-pathway mutated paediatric and adult acute lymphoblastic leukaemia (SeluDex): study proto... by Sarah Johnson, Geoff Shenton, Ruth Plummer, Joshua Savage, Gareth J Veal, Julie Irving, Lucinda Billingham, Pamela Kearns, Daniel Slade, Tobias Menne, Britta Vormoor, Josef Vormoor

    Published 2022-03-01
    Get full text
    Article
  4. 4
    Establishment and validation of a standard protocol for the detection of minimal residual disease in B lineage childhood acute lymphoblastic leukemia by flow cytometry in a multi-center setting;

    Establishment and validation of a standard protocol for the detection of minimal residual disease in B lineage childhood acute lymphoblastic leukemia by flow cytometry in a multi-c... by Julie Irving, Jenny Jesson, Paul Virgo, Marian Case, Lynne Minto, Lisa Eyre, Nigel Noel, Ulrika Johansson, Marion Macey, Linda Knotts, Margaret Helliwell, Paul Davies, Liam Whitby, David Barnett, Jeremy Hancock, Nick Goulden, Sarah Lawson

    Published 2009-06-01
    Get full text
    Article
  5. 5
    PB1725: INTERNATIONAL LEUKEMIA TARGET BOARD - A PLATFORM TO DISCUSS AND PRIORITIZE TARGETED TREATMENT OPTIONS FOR PATIENTS WITH RELAPSED/REFRACTORY PEDIATRIC HEMATOLOGICAL MALIGNANCIES (ILTB) – ITCC 107

    PB1725: INTERNATIONAL LEUKEMIA TARGET BOARD - A PLATFORM TO DISCUSS AND PRIORITIZE TARGETED TREATMENT OPTIONS FOR PATIENTS WITH RELAPSED/REFRACTORY PEDIATRIC HEMATOLOGICAL MALIGNAN... by Uri Ilan, Judith M. Boer, Birgit Burkhardt, Frederik van Delft, Shai Izraeli, Jan-Henning Klusmann, Barbara De Moerloose, Pablo Velasco, Julie Irving, José Luis Fuster, Dániel Erdélyi, Andreas E Kulozik, Dirk Reinhardt, Michel Zwaan, Monique L. den Boer

    Published 2023-08-01
    Get full text
    Article

Search Tools: